Literature DB >> 18407307

Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells.

Gerson A Soto-Peña1, Libia Vega.   

Abstract

Arsenic is known to produce inhibition as well as induction of immune cells proliferative responses depending on the doses as one of its mechanisms of immunotoxicity. Here we evaluate the effect of arsenic exposure on the activation of splenic mononuclear cells (SMC) in male CD57BL6N mice. Intra-gastric exposure to arsenic (as sodium arsenite) for 30 days (1, 0.1, or 0.01 mg/kg/day), reduced the proportion of CD4+ cells and the CD4+/CD8+ ratio in the spleen, increasing the proportion of CD11b+ cells. Arsenic exposure did not modify the proportion of B cells. SMC showed an increased level of phosphorylation of lck and fyn kinases (first kinases associated to TCR complex when activated). Although normal levels of apoptosis were observed on freshly isolated SMC, an increase in apoptotic cells related with the increase in phosphorylation of lck and fyn was observed when SMC were activated with Concanavalin-A (Con-A). Arsenic exposure reduced the proliferative response of SMC to Con-A, and also reduced secretion of IL-2, IL-6, IL-12 and IFNgamma. No effect was observed on IL-4, and IL-10 secretion. The same effects were observed when SMC of exposed animals were activated with anti-CD3/CD28 antibodies for 24 h, but these effects were transitory since a recovery, up to control levels or even higher, were observed after 72 h of stimulation. This study demonstrates that repeated and prolonged exposure to arsenic alters cell populations and produces functional changes depending on the specific activation pathway, and could be related with the phosphorylation status of lck and fyn kinases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18407307     DOI: 10.1016/j.taap.2008.02.029

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  13 in total

1.  Arsenic exposure and hepatitis E virus infection during pregnancy.

Authors:  Christopher D Heaney; Brittany Kmush; Ana Navas-Acien; Kevin Francesconi; Walter Gössler; Kerry Schulze; DeLisa Fairweather; Sucheta Mehra; Kenrad E Nelson; Sabra L Klein; Wei Li; Hasmot Ali; Saijuddin Shaikh; Rebecca D Merrill; Lee Wu; Keith P West; Parul Christian; Alain B Labrique
Journal:  Environ Res       Date:  2015-07-15       Impact factor: 6.498

Review 2.  Old dog, new trick: Trivalent arsenic as an immunomodulatory drug.

Authors:  Yishan Ye; Béatrice Gaugler; Mohamad Mohty; Florent Malard
Journal:  Br J Pharmacol       Date:  2020-03-12       Impact factor: 8.739

Review 3.  Arsenic and Immune Response to Infection During Pregnancy and Early Life.

Authors:  Sarah E Attreed; Ana Navas-Acien; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2017-06

4.  Arsenic inhibits mast cell degranulation via suppression of early tyrosine phosphorylation events.

Authors:  Juyoung Shim; Rachel H Kennedy; Lisa M Weatherly; Lee M Hutchinson; Jonathan H Pelletier; Hina N Hashmi; Kayla Blais; Alejandro Velez; Julie A Gosse
Journal:  J Appl Toxicol       Date:  2016-03-28       Impact factor: 3.446

5.  Low-level arsenic causes chronic inflammation and suppresses expression of phagocytic receptors.

Authors:  Priyanka Prasad; Dona Sinha
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-22       Impact factor: 4.223

Review 6.  Arsenic Exposure and Immunotoxicity: a Review Including the Possible Influence of Age and Sex.

Authors:  Daniele Ferrario; Laura Gribaldo; Thomas Hartung
Journal:  Curr Environ Health Rep       Date:  2016-03

Review 7.  Arsenic immunotoxicity: a review.

Authors:  Nygerma L Dangleben; Christine F Skibola; Martyn T Smith
Journal:  Environ Health       Date:  2013-09-02       Impact factor: 5.984

8.  Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous acid.

Authors:  Scott W Burchiel; Fredine T Lauer; Ellen J Beswick; A Jay Gandolfi; Faruque Parvez; Ke Jian Liu; Laurie G Hudson
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

9.  Levocetirizine inhibits migration of immune cells to lymph nodes and induces treg cells in a murine type I allergic conjunctivitis model.

Authors:  Sihomara García-Zepeda; Elizabet Estrada-Muñiz; Guillermo Elizondo; Luis I Terrazas; Miriam Rodríguez-Sosa; Juan D Quintana-Hau; Rubén Tornero-Montaño; Leopoldo Baiza-Durán; Libia Vega
Journal:  Open Ophthalmol J       Date:  2012-12-14

10.  Early life arsenic exposure and acute and long-term responses to influenza A infection in mice.

Authors:  Kathryn A Ramsey; Rachel E Foong; Peter D Sly; Alexander N Larcombe; Graeme R Zosky
Journal:  Environ Health Perspect       Date:  2013-08-22       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.